Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Neuroscience Letters

• Publication date

  1992-12-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0304-3940(92)90839-YPMID 1284442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• τ Protein Kinase II Is Involved in the Regulation of the Normal Phosphorylation State of τ Protein

  1993cited by this paper
• Tau protein kinase II is involved in the regulation of the normal phosphorylation state of tau protein.

  1993cited by this paper
• The switch of tau protein to an Alzheimer‐like state includes the phosphorylation of two serine‐proline motifs upstream of the microtubule binding region.

  1992cited by this paper
• A protein kinase associated with paired helical filaments in Alzheimer disease.

  1992cited by this paper
• The Alzheimer‐like phosphorylation of tau protein reduces microtubule binding and involves Ser‐Pro and Thr‐Pro motifs

  1992cited by this paper
• Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments.

  1992cited by this paper
• Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain.

  1992cited by this paper
• Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state.

  1992cited by this paper
• Fetal-type phosphorylation of the tau in paired helical filaments.

  1992cited by this paper
• Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease

  1992cited by this paper
• Fetal‐Type Phosphorylation of the τ in Paired Helical Filaments

  1992cited by this paper
• A serine/threonine proline kinase activity is included in the tau protein kinase fraction forming a paired helical filament epitope.

  1991cited by this paper
• Tau protein binds to microtubules through a flexible array of distributed weak sites

  1991cited by this paper
• Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios

  1991cited by this paper
• Improved protective groups for phosphate of o-phosphoserine useful for the solid-phase peptide synthesis

  1991cited by this paper
• A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

  1991cited by this paper
• Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

  1989cited by this paper
• Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains

  1989cited by this paper
• The carboxyl third of tau is tightly bound to paired helical filaments.

  1988cited by this paper
• Microtubule-binding domain of tau proteins.

  1988cited by this paper
• Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease.

  1988cited by this paper
• A novel tubulin-dependent protein kinase forming a paired helical filament epitope on tau.

  1988cited by this paper
• Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.

  1988cited by this paper
• Epitopes that span the tau molecule are shared with paired helical filaments.

  1988cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein? (tau) in Alzheimer cytoskeletal pathology

  1987cited by this paper
• Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease.

  1986cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

  1986cited by this paper
• A protein factor essential for microtubule assembly.

  1975cited by this paper

• Targeting of Kinases to Treat Neurodegenerative Diseases

  2026cites this paper
• Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease

  2025cites this paper
• Cellular and molecular mechanisms of pathological tau phosphorylation in traumatic brain injury: implications for chronic traumatic encephalopathy

  2025cites this paper
• Non-canonical Pathways Associated to Amyloid Beta and Tau Protein Dyshomeostasis in Alzheimer's disease: a narrative review.

  2024cites this paper
• The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities

  2023cites this paper
• Tau, tau kinases, and tauopathies: An updated overview

  2023influential citation
• The Adult Neurogenesis Theory of Alzheimer’s Disease

  2023cites this paper
• Recent advances in drug repurposing using machine learning.

  2021cites this paper
• Lithium modulates multiple tau kinases with distinct effects in cortical and hippocampal neurons according to concentration ranges

  2021cites this paper
• Tau‐induced upregulation of C/EBPβ‐TRPC1‐SOCE signaling aggravates tauopathies: A vicious cycle in Alzheimer neurodegeneration

  2020cites this paper
• Machine Learning for Discovery of GSK3β Inhibitors

  2020cites this paper
• Tau tubulin kinases in proteinopathy

  2019cites this paper
• Structural Basis for Achieving GSK-3 β Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug Discovery

  2019cites this paper
• Structural Basis for Achieving GSK-3 Inhibition with High Potency, Selectivity and Brain Exposure for PET Imaging and Drug Discovery.

  2019cites this paper
• Melatonin – Stellenwert in der Pathophysiologie und Therapie der Demenz vom Alzheimertyp

  2019cites this paper
• Insulin-Mediated Changes in Tau Hyperphosphorylation and Autophagy in a Drosophila Model of Tauopathy and Neuroblastoma Cells

  2019cites this paper
• It’s all about tau

  2019cites this paper
• Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy

  2018cites this paper
• AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration.

  2017cites this paper
• Mechanisms of Melatonin in Alleviating Alzheimer’s Disease

  2017influential citation
• Tibolone modulates neuronal plasticity through regulating Tau, GSK3β/Akt/PI3K pathway and CDK5 p35/p25 complexes in the hippocampus of aged male mice

  2017cites this paper
• Indirubin-3′-monoxime suppresses amyloid-beta-induced apoptosis by inhibiting tau hyperphosphorylation

  2016cites this paper
• Diabetes Mellitus Induces Alzheimer’s Disease Pathology: Histopathological Evidence from Animal Models

  2016cites this paper
• TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson's disease

  2016cites this paper
• Passive immunotherapy of tauopathy targeting pSer413-tau: a pilot study in mice

  2015cites this paper
• Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

  2015cites this paper
• The Potential Therapeutic Effects of THC on Alzheimer's Disease

  2014cites this paper
• Physiological and pathological phosphorylation of tau by Cdk5

  2014influential citation
• Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats

  2014cites this paper
• Tau-tubulin kinase

  2014cites this paper
• Natural Compounds (Small Molecules) as Potential and Real Drugs of Alzheimer's Disease

  2014cites this paper
• Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L×GSK3β mice by delaying brainstem tauopathy.

  2014cites this paper
• Role of NMDA receptors in noise-induced tau hyperphosphorylation in rat hippocampus and prefrontal cortex.

  2014cites this paper
• Glycogen synthase kinase‐3β (GSK3β) expression in a mouse model of Alzheimer's disease: A light and electron microscopy study

  2013cites this paper
• Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer’s disease with PS1 mutations

  2013cites this paper
• X‐ray Structural Analysis of Tau‐Tubulin Kinase 1 and Its Interactions with Small Molecular Inhibitors

  2013cites this paper
• Glycogen Synthase Kinase 3β (GSK3β) Modulates Antiviral Activity of Zinc-finger Antiviral Protein (ZAP)*

  2012cites this paper
• Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated by N-Methyl-d-aspartate Receptor-dependent Tau Phosphorylation*

  2012cites this paper
• Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: tangle formation, amyloid-β, and microglia in Alzheimer's disease.

  2012cites this paper
• Cellular model of Alzheimer's disease--relevance to therapeutic testing.

  2012cites this paper
• Chronic noise exposure causes persistence of tau hyperphosphorylation and formation of NFT tau in the rat hippocampus and prefrontal cortex.

  2012cites this paper
• L'impact du diabète de type 2 sur la phosphorylation de tau in vivo

  2011cites this paper
• The possible involvement of glycogen synthase kinase-3 (GSK-3) in diabetes, cancer and central nervous system diseases.

  2011cites this paper
• Alzheimer’s Disease: Lessons from Cell Biology

  2011cites this paper
• Regulation of Cell Survival Mechanisms in Alzheimer's Disease by Glycogen Synthase Kinase-3

  2011cites this paper
• Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src.

  2011cites this paper
• [Pathological changes induced by amyloid-β in Alzheimer's disease].

  2011cites this paper
• Stimulatory effect of α‐synuclein on the tau‐phosphorylation by GSK‐3β

  2011cites this paper
• Relationship of Adult Neurogenesis with Tau Phosphorylation and GSK-3β Activity in Subventricular Zone

  2011cites this paper
• The biochemical study on the etiology of Alzheimer’s disease

  2010cites this paper
• Tau‐tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP‐17 tau‐mutant mice

  2010cites this paper
• Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease.

  2010cites this paper
• Spectroscopic Studies of GSK3β Phosphorylation of the Neuronal Tau Protein and Its Interaction with the N-terminal Domain of Apolipoprotein E

  2010cites this paper
• Role of glycogen synthase kinase-3 in Alzheimer’s disease pathogenesis and glycogen synthase kinase-3 inhibitors

  2010cites this paper
• Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen

  2010cites this paper
• Modulation of growth factor-induced ERK signaling by the microtubule associated protein tau

  2010influential citation
• Essential role of tau phosphorylation in adult hippocampal neurogenesis

  2010cites this paper
• Tau Potentiates Nerve Growth Factor-induced Mitogen-activated Protein Kinase Signaling and Neurite Initiation without a Requirement for Microtubule Binding*

  2010cites this paper
• GSK‐3: A key player in neurodegeneration and memory

  2009cites this paper
• Spatial Learning Impairment, Enhanced CDK5/p35 Activity, and Downregulation of NMDA Receptor Expression in Transgenic Mice Expressing Tau-Tubulin Kinase 1

  2008cites this paper
• Upregulation of GSK3beta expression in frontal and temporal cortex in ALS with cognitive impairment (ALSci).

  2008cites this paper
• Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin

  2008cites this paper
• The GSK3 hypothesis of Alzheimer's disease

  2008influential citation
• ER stress is involved in Aβ‐induced GSK‐3β activation and tau phosphorylation

  2008cites this paper
• Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats.

  2007cites this paper
• Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

  2007cites this paper
• Fibrillogenic Nuclei Composed of P301L Mutant Tau Induce Elongation of P301L Tau but Not Wild-type Tau*

  2007cites this paper
• Increased level of active GSK‐3β in Alzheimer’s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration

  2007cites this paper
• Tau phosphorylation in the mouse brain during aversive conditioning.

  2007cites this paper
• GSK-3 inhibitors for Alzheimer’s disease

  2007cites this paper
• In vitro modelling of tau phosphorylating kinases : emphasis of Cdk5

  2007cites this paper
• Reelin Signals through Phosphatidylinositol 3-Kinase and Akt To Control Cortical Development and through mTor To Regulate Dendritic Growth

  2007cites this paper
• Identification of small molecules that interfere with radial neuronal migration and early cortical plate development.

  2006cites this paper
• Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism.

  2006cites this paper
• Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta.

  2006cites this paper
• GSK3alpha exhibits beta-catenin and tau directed kinase activities that are modulated by Wnt.

  2006cites this paper
• Tau‐tubulin kinase 1 (TTBK1), a neuron‐specific tau kinase candidate, is involved in tau phosphorylation and aggregation

  2006cites this paper
• Increased tau phosphorylation at the Ser396 epitope after amyloid beta-exposure in organotypic cultures

  2006cites this paper
• GSK3α exhibits β‐catenin and tau directed kinase activities that are modulated by Wnt

  2006cites this paper
• Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance

  2006cites this paper
• NSE-Controlled Carboxyl-Terminus of APP Gene Over-Expressing in Transgenic Mice Induces Altered Expressions in Behavior, Aβ-42, and GSK3β Binding Proteins

  2005cites this paper
• Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes

  2005cites this paper
• Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes.

  2005cites this paper
• Post-translational modifications of tau protein in Alzheimer’s disease

  2005cites this paper
• Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM).

  2005cites this paper
• GSK3 inhibitors: development and therapeutic potential

  2004cites this paper
• Phosphorylation of microtubule‐associated protein tau by isoforms of c‐Jun N‐terminal kinase (JNK)

  2004cites this paper
• Akt/GSK3beta serine/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations.

  2004cites this paper
• Inactivation of glycogen synthase kinase-3beta protects against kainic acid-induced neurotoxicity in vivo.

  2004cites this paper
• The role of GSK‐3β in the formation of neurofibrillary tangles

  2004cites this paper
• Estrogen-induced cell signalling in a cellular model of Alzheimer's disease.

  2003cites this paper
• Developmental Regulation of the Proteolysis of the p35 Cyclin-Dependent Kinase 5 Activator by Phosphorylation

  2003cites this paper
• Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease.

  2003cites this paper
• Stress‐induced hyperphosphorylation of tau in the mouse brain

  2003cites this paper
• Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology

  2003cites this paper
• Age-related changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains.

  2003cites this paper
• P24, a glycogen synthase kinase 3 (GSK 3) inhibitor.

  2002cites this paper
• Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3β

  2002cites this paper
• Glycogen Synthase Kinase-3β Is Complexed with Tau Protein in Brain Microtubules*

  2002cites this paper
• Discovery of compounds that will prevent tau pathology

  2002cites this paper